CHC Healthcare (Taiwan) Performance
| 4164 Stock | TWD 51.30 0.90 1.72% |
On a scale of 0 to 100, CHC Healthcare holds a performance score of 13. The firm owns a Beta (Systematic Risk) of 0.43, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, CHC Healthcare's returns are expected to increase less than the market. However, during the bear market, the loss of holding CHC Healthcare is expected to be smaller as well. Please check CHC Healthcare's mean deviation, downside deviation, standard deviation, as well as the relationship between the semi deviation and coefficient of variation , to make a quick decision on whether CHC Healthcare's current price history will revert.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in CHC Healthcare Group are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, CHC Healthcare showed solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 1.4 B | |
| Total Cashflows From Investing Activities | -990.4 M |
CHC |
CHC Healthcare Relative Risk vs. Return Landscape
If you would invest 4,145 in CHC Healthcare Group on December 25, 2024 and sell it today you would earn a total of 985.00 from holding CHC Healthcare Group or generate 23.76% return on investment over 90 days. CHC Healthcare Group is generating 0.4196% of daily returns and assumes 2.5286% volatility on return distribution over the 90 days horizon. Simply put, 22% of stocks are less volatile than CHC, and 92% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
CHC Healthcare Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for CHC Healthcare's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as CHC Healthcare Group, and traders can use it to determine the average amount a CHC Healthcare's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1659
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 4164 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.53 actual daily | 22 78% of assets are more volatile |
Expected Return
| 0.42 actual daily | 8 92% of assets have higher returns |
Risk-Adjusted Return
| 0.17 actual daily | 13 87% of assets perform better |
Based on monthly moving average CHC Healthcare is performing at about 13% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CHC Healthcare by adding it to a well-diversified portfolio.
CHC Healthcare Fundamentals Growth
CHC Stock prices reflect investors' perceptions of the future prospects and financial health of CHC Healthcare, and CHC Healthcare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CHC Stock performance.
| Return On Equity | 0.0713 | |||
| Return On Asset | 0.0265 | |||
| Profit Margin | 0.14 % | |||
| Operating Margin | 0.17 % | |||
| Current Valuation | 10.86 B | |||
| Shares Outstanding | 161.54 M | |||
| Price To Earning | 22.05 X | |||
| Price To Book | 1.23 X | |||
| Price To Sales | 2.46 X | |||
| Revenue | 2.44 B | |||
| EBITDA | 1.01 B | |||
| Cash And Equivalents | 1.3 B | |||
| Cash Per Share | 9.36 X | |||
| Total Debt | 3.89 B | |||
| Debt To Equity | 95.80 % | |||
| Book Value Per Share | 37.53 X | |||
| Cash Flow From Operations | 692.79 M | |||
| Earnings Per Share | 2.26 X | |||
| Total Asset | 12.57 B | |||
| Retained Earnings | 710 M | |||
| Current Asset | 2.37 B | |||
| Current Liabilities | 1.08 B | |||
About CHC Healthcare Performance
Evaluating CHC Healthcare's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if CHC Healthcare has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if CHC Healthcare has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
CHC Healthcare Group, through its subsidiaries, engages in the distribution, repair and maintenance, and lease of the medical equipment and related parts, consumables, and medicines in Taiwan, China, and internationally. The company was founded in 1977 and is headquartered in Taipei City, Taiwan. CHC HEALTHCARE is traded on Taiwan Stock Exchange in Taiwan.Things to note about CHC Healthcare Group performance evaluation
Checking the ongoing alerts about CHC Healthcare for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for CHC Healthcare Group help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CHC Healthcare Group has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| About 42.0% of the company shares are owned by insiders or employees |
- Analyzing CHC Healthcare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CHC Healthcare's stock is overvalued or undervalued compared to its peers.
- Examining CHC Healthcare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CHC Healthcare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CHC Healthcare's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CHC Healthcare's stock. These opinions can provide insight into CHC Healthcare's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for CHC Stock Analysis
When running CHC Healthcare's price analysis, check to measure CHC Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CHC Healthcare is operating at the current time. Most of CHC Healthcare's value examination focuses on studying past and present price action to predict the probability of CHC Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CHC Healthcare's price. Additionally, you may evaluate how the addition of CHC Healthcare to your portfolios can decrease your overall portfolio volatility.